|
|
|
|
|
|
|
|
|
|
|
11.12.25 - 19:30
|
The UK′s pharma deal was vital – but the GSK boss is right about US dominance (The Guardian)
|
|
|
It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pactThat's gratitude, eh? It's not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, the UK's second largest pharma firm, to extol the virtues of doing business in the US.The US is “still the leading market in the world in terms of the launches of new drugs and vaccines,” said the chief executive, Emma Walmsley, in a BBC interview, explaining why GSK invests about three times as much over there as it does at home. Alongside China, the US is also “the best market in the world to do business development”. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.12.25 - 16:48
|
Reaching net zero: what will it cost the UK and is it a price worth paying? (The Guardian)
|
|
|
An official report says the bill for switching to clean energy will rise sharply – and puts forward a slower, 'falling behind” alternativeThe cost of hitting net zero targets has been laid bare by the UK's energy system operator, showing a surge in spending over the coming years.But investing in clean generation projects, distribution networks and replacing fossil fuel cars and boilers could be many billions of pounds cheaper if the UK was less ambitious, according to Thursday's report. The downside would be that the benefits, which include far lower energy costs, would be delayed. Continue reading......
|
|
|
|
Alle News zu Großbritannien 9721.697 +0.43% (FTSE 100 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
